Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

Successful Pre- and Posttransplant Sofosbuvir-Based Anti-Hepatitis C Virus Treatment in Persons Living With Human Immunodeficiency Virus Infection.

Guaraldi G, Rossotti R, Verucchi G, Tavio M, Pasulo L, Beghetto B, Dolci G, Nardini G, Badia L, Magliano A, Moioli MC, Puoti M; HIV/HCV Italian Liver Transplant Group .

Open Forum Infect Dis. 2017 May 29;4(2):ofx065. doi: 10.1093/ofid/ofx065. eCollection 2017 Spring.

2.

Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL.

Madeddu G, Rusconi S, Cozzi-Lepri A, Di Giambenedetto S, Bonora S, Carbone A, De Luca A, Gianotti N, Di Biagio A, Antinori A; Icona Foundation Study Group.

Infection. 2017 May 5. doi: 10.1007/s15010-017-1018-z. [Epub ahead of print]

PMID:
28477212
3.

Electrophysiological Adverse Effects of Direct-Acting Antivirals in Patients With Chronic Hepatitis C.

Rossotti R, Garcia-Fraile Fraile LJ, Baiguera C, Puoti M.

J Clin Pharmacol. 2017 Jul;57(7):931-932. doi: 10.1002/jcph.905. Epub 2017 May 3. No abstract available.

PMID:
28467638
4.

Letter: sustained virological response and liver healing.

Rossotti R, Garcia-Fraile Fraile LJ, Baiguera C, Puoti M.

Aliment Pharmacol Ther. 2017 Apr;45(8):1171-1173. doi: 10.1111/apt.13982. No abstract available.

PMID:
28326575
5.

Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus.

Puoti M, Lorenzini P, Cozzi-Lepri A, Gori A, Mastroianni C, Rizzardini G, Mazzarello G, Antinori A, d'Arminio Monforte A, Girardi E; Icona Foundation Study Group.

Clin Microbiol Infect. 2017 Apr;23(4):267.e1-267.e4. doi: 10.1016/j.cmi.2016.12.003. Epub 2016 Dec 9.

PMID:
27956268
6.

Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection.

Arcaini L, Besson C, Frigeni M, Fontaine H, Goldaniga M, Casato M, Visentini M, Torres HA, Loustaud-Ratti V, Peveling-Oberhag J, Fabris P, Rossotti R, Zaja F, Rigacci L, Rattotti S, Bruno R, Merli M, Dorival C, Alric L, Jaccard A, Pol S, Carrat F, Ferretti VV, Visco C, Hermine O.

Blood. 2016 Nov 24;128(21):2527-2532. Epub 2016 Sep 7.

PMID:
27605512
7.

Impact of circulating resistance-associated mutations on HIV pre-exposure prophylaxis (PrEP) efficacy: Modeling from antiretroviral resistance cohort analysis (ARCA) national database.

Rossotti R, Borghi V, Callegaro AP, Micheli V, Bruzzone B, Colao G, Gismondo MR, Vicenti I, Penco G, Zazzi M, Rusconi S.

J Clin Virol. 2016 Oct;83:48-53. doi: 10.1016/j.jcv.2016.08.293. Epub 2016 Aug 23.

PMID:
27591555
8.

Treatment of hepatitis C virus genotype 1-infected patients: mission accomplished?

Puoti M, Rossotti R, Baiguera C, Orso M.

Liver Int. 2016 Feb;36(2):181-4. doi: 10.1111/liv.13040. No abstract available.

PMID:
26781595
9.

Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus.

Mussini C, Lorenzini P, Puoti M, Lichtner M, Lapadula G, Di Giambenedetto S, Antinori A, Madeddu G, Cozzi-Lepri A, d'Arminio Monforte A, De Luca A; ICONA Foundation Study Group.

PLoS One. 2015 Dec 7;10(12):e0140877. doi: 10.1371/journal.pone.0140877. eCollection 2015.

10.

Efficacy of sofosbuvir-based therapies in HIV/HCV infected patients and persons who inject drugs.

Puoti M, Panzeri C, Rossotti R, Baiguera C.

Dig Liver Dis. 2014 Dec 15;46 Suppl 5:S206-11. doi: 10.1016/j.dld.2014.09.027. Epub 2014 Nov 7. Review.

11.

Rapid clearance of HCV-related splenic marginal zone lymphoma under an interferon-free, NS3/NS4A inhibitor-based treatment. A case report.

Rossotti R, Travi G, Pazzi A, Baiguera C, Morra E, Puoti M.

J Hepatol. 2015 Jan;62(1):234-7. doi: 10.1016/j.jhep.2014.09.031. Epub 2014 Oct 5.

PMID:
25285757
12.

Rilpivirine resistance and the dangerous liaisons with substitutions at position 184 among patients infected with HIV-1: analysis from a national drug-resistance database (ARCA).

Rossotti R, Fonte L, Meini G, Maggiolo F, Zazzi M, Rusconi S; ARCA Collaborative Group.

J Med Virol. 2014 Sep;86(9):1459-66. doi: 10.1002/jmv.23978. Epub 2014 May 17.

PMID:
24838991
13.

Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study.

Worm SW, Bower M, Reiss P, Bonnet F, Law M, Fätkenheuer G, d'Arminio Monforte A, Abrams DI, Grulich A, Fontas E, Kirk O, Furrer H, De Wit S, Phillips A, Lundgren JD, Sabin CA; D:A:D Study Group.

BMC Infect Dis. 2013 Oct 9;13:471. doi: 10.1186/1471-2334-13-471.

14.

Optimizing treatment in HIV/HCV coinfection.

Puoti M, Rossotti R, Travi G, Panzeri C, Morreale M, Chiari E, Cocca G, Orso M, Moioli MC.

Dig Liver Dis. 2013 Sep 30;45 Suppl 5:S355-62. doi: 10.1016/j.dld.2013.09.001. Review.

PMID:
24091116
15.

Associations between immune depression and cardiovascular events in HIV infection.

Sabin CA, Ryom L, De Wit S, Mocroft A, Phillips AN, Worm SW, Weber R, D'Arminio Monforte A, Reiss P, Kamara D, El-Sadr W, Pradier C, Dabis F, Law M, Lundgren J; D:A:D Study Group.

AIDS. 2013 Nov 13;27(17):2735-48. doi: 10.1097/01.aids.0000432457.91228.f3.

PMID:
23842128
16.

Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study.

Ryom L, Mocroft A, Kirk O, Worm SW, Kamara DA, Reiss P, Ross M, Fux CA, Morlat P, Moranne O, Smith C, Lundgren JD; D:A:D Study Group.

J Infect Dis. 2013 May 1;207(9):1359-69. doi: 10.1093/infdis/jit043. Epub 2013 Feb 4.

17.

Top topics in HCV research arena.

Puoti M, Rossotti R, Travi G, Orso M, Moioli MC.

BMC Infect Dis. 2012;12 Suppl 2:S7. doi: 10.1186/1471-2334-12-S2-S7. Epub 2012 Nov 12. Review.

18.

Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics.

May MT, Hogg RS, Justice AC, Shepherd BE, Costagliola D, Ledergerber B, Thiébaut R, Gill MJ, Kirk O, van Sighem A, Saag MS, Navarro G, Sobrino-Vegas P, Lampe F, Ingle S, Guest JL, Crane HM, D'Arminio Monforte A, Vehreschild JJ, Sterne JA; Antiretroviral Therapy Cohort Collaboration (ART-CC).

Int J Epidemiol. 2012 Dec;41(6):1807-20. doi: 10.1093/ije/dys164. Epub 2012 Nov 12.

19.

FDG-PET imaging in the diagnosis of HIV-associated multicentric Castleman disease: something is still missing.

Rossotti R, Moioli C, Schiantarelli C, Orcese C, Puoti M.

Top Antivir Med. 2012 Aug-Sep;20(3):116-8.

20.

Human immunodeficiency virus and hepatitis C virus coinfection: the agenda is full while waiting for new drugs.

Puoti M, Moioli MC, Rossotti R, Travi G, Bruno R.

Hepatology. 2013 Jan;57(1):4-6. doi: 10.1002/hep.25941. No abstract available.

PMID:
22806438

Supplemental Content

Loading ...
Support Center